pCD565
(Plasmid
#153027)
-
PurposedxCas9(3.7), MCP-SoxS(R93A/S101A), J306 scRNA
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 153027 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonep15A vector
-
Vector typeBacterial Expression, CRISPR
Growth in Bacteria
-
Bacterial Resistance(s)Chloramphenicol, 25 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namedxCas9(3.7), MCP-SoxS(R93A/S101A), J306 scRNA
-
SpeciesEvolved (dxCas9(3.7)), MS2 (MCP), E. coli (SoxS), synthetic (J306 scRNA)
-
MutationSoxS has R93A and S101A mutations
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made bydxCas9(3.7) was a gift from David Liu
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCD565 was a gift from Jesse Zalatan (Addgene plasmid # 153027 ; http://n2t.net/addgene:153027 ; RRID:Addgene_153027) -
For your References section:
Effective CRISPRa-mediated control of gene expression in bacteria must overcome strict target site requirements. Fontana J, Dong C, Kiattisewee C, Chavali VP, Tickman BI, Carothers JM, Zalatan JG. Nat Commun. 2020 Apr 1;11(1):1618. doi: 10.1038/s41467-020-15454-y. 10.1038/s41467-020-15454-y PubMed 32238808